The Supreme Court unanimously ruled that The Alliance for Hippocratic Medicine and the doctors it represented did not have adequate proof of standing to sue the FDA, providing the agency relief from potential endless litigation. Standing is the right of a person or organization to sue another entity and is determined by whether the party has suffered a concrete injury directly attributable to the action in question. In this case, the Alliance for Hippocratic Medicine sued the FDA over the approval of the abortion drug mifepristone, claiming harm by a series of associated harms when treating mifepristone patients. However, the Supreme Court found that the doctors lacked standing to challenge FDA’s actions regarding mifepristone regulation. The court dismissed the complicated causation theories presented by the plaintiffs and found that the link between FDA’s actions and the alleged injuries was too speculative. The court emphasized that doctors cannot challenge the government’s actions based on potential future injuries, and that concerns should be addressed through the Executive and Legislative branches rather than through legal action. The Court’s decision is significant as it maintains the bar for plaintiffs to establish standing, preventing regulatory agencies like the FDA from facing a barrage of lawsuits from individuals claiming indirect harm. This decision provides a potential respite for the FDA and upholds the principle that a party must show demonstrable harms to establish standing, preventing frivolous lawsuits that could undermine regulatory authority.